Table 3

Characteristics of infants with ROP specified per stage

nGABWScreeningsPlus disease (n)Treated (n)Type 1 (n)
No ROP78029.6 (24.0–34.9)1210 (500–2900)2 (1–10)NANANA
ROP 115928.1 (24.4–32.1)1020 (450–2350)4 (1–10)100
ROP 29726.7 (24.0–31.4)898 (520–1530)6 (1–17)988
ROP 34425.7 (24.0–30.9)750 (410–1415)10 (2–19)262625
ROP 4226.0 (25.6–26.4)621 (578–665)14 (9–19)222
ROP 5126.152027111
APROP225.9 (25.1–26.6)893 (785–1000)7 (5–8)222
  • Number of screenings shown as median (minimum–maximum range).

  • APROP, aggressive posterior ROP; BW, birth weight (g); GA, gestational age (weeks); ROP, retinopathy of prematurity.